A systematic approach to benchmark conversion helps companies maximise their compression of legacy benchmark gross notional. TriOptima looks into the effects produced by its recently introduced triReduce Benchmark Conversion functionality.
In October 2020, we saw the official launch of our triReduce Benchmark Conversion functionality that facilitates the proactive reduction of exposure to legacy benchmarks. Much has been written about the future of interest rate benchmarks, but all we can say for certain is that the future is anything but. As a number of regulators recently updated their recommendations for legacy benchmarks, TriOptima is able to support customers in transitioning their OTC swap portfolios to the alternative benchmarks.
Moving towards the most efficient form of legacy benchmark risk
12 months ago, we began the journey to increase awareness of how triReduce’s leading multilateral compression network could form the foundation of a robust and effective conversion mechanism on to alternative benchmarks. We demonstrated the value of our existing compression activities as well as providing a window into the future where each individual party can proactively perform their transition.
The basic tenets start with maximising compression opportunities to remain as close to the core net risk position in legacy benchmarks. This objective can be achieved by focusing on participation, trade submission and risk tolerances.
Fig 1. Participation, trade submission and risk tolerances
We conducted a series of coordinated simulations to demonstrate the potential in these keys areas to each customer in quantifiable terms. This included a thorough examination of their compression activity and untapped potential, which can be visualised through the reverse waterfall below. The conversations that followed helped to shed light on the great work that was already being done; clear guidelines for how service utilisation could be improved further; as well as establishing a comprehensive playbook for how back book transition could occur with the adoption of triReduce’s Benchmark Conversion functionality.
Reverse Waterfall of Compression Potential
The mechanism for converting what remains
In preparation for the second part of the process, where legacy risk can be converted into the alternative benchmark, we have delivered functionality for risk replacement trades based on trade templates that have been made available by CCPs. These templates are particularly important in portfolios where insufficient volume in the alternative benchmark exists. In this case, we can use the templates to obtain valuations and risk sensitivities from each participating firm’s own mid-market curves.
As shown in the chart, risk replacement trades are initially being used to further maximise the compression of legacy benchmark gross notional. At this time, the early adopters are experiencing up to 40% greater reduction in post-2021 ICE Libor gross notional through our regular triReduce cleared compression cycles. Meaning that iteratively over time, they will find themselves in the best possible position to handle whatever eventuality materialises after the end of 2021.
Maintaining best practices in alternative benchmark portfolios
While our customers focus on ensuring they maintain the most efficient legacy benchmark portfolio possible, they are also making certain that they are implementing the best risk management practices for the increasing number of alternative benchmark trades in their portfolios. One of the ways they are doing this is to review their trade extracts that feed into the compression process, to ensure that these new trades are being captured. In turn they can verify these trades are being priced and risk measured consistently and correctly through our unique pre-compression reconciliation checks. Here participants can also confirm their valuations against those determined by the CCP in one integral process, providing them with the confidence that when the alternative benchmark trades are compressed, they are done within accurate NPV and risk boundaries.
Another way in which our customers are extending best practices to alternative benchmark trades is by validating they can not only execute trades on the new benchmarks, but also price, risk manage and process trade lifecycle events on these trades. Here we once again lend our support to market participants by guiding them through submission into our compression cycles, so they can confirm that beyond entering into such trades, they are also able to exit out of them when the appropriate time comes.
A comprehensive solution for managing a legacy benchmark back book
triReduce supports all approved alternative benchmarks in addition to regularly compressing trades on USD SOFR, €STR, GBP SONIA, JPY TONA, CHF SARON, CAD CORRA, & AUD AONIA. Extensive investment has been made towards developing a fully scalable infrastructure enabling triReduce to offer a comprehensive solution for managing benchmark transition in legacy portfolios.
Delivering certainty when performing compression and conversion at scale is what sets triReduce’s Benchmark Conversion functionality apart. We are already looking to take the lessons learned in our cycles, on to other applications beyond the ICE Libor benchmarks. As the industry seeks solutions in the EONIA to €STR transition, this conversion functionality and these valuation submission checks will continue to play an important role in 2021.
When thinking about 2021 and the challenges that lie ahead, market participants can expect to need to evaluate all possible transition management options. Adherence to the ISDA Protocol for legacy contracts is certainly a top consideration. However, a fully-fledged strategy for transition doesn’t end there. It extends to a continued effort to mitigate legacy benchmark exposures, at the same time as ensuring readiness to hold alternative benchmark trades in the portfolio. Compression plays an integral role here and with it, Benchmark Conversion will offer a vital mechanism for transitioning between benchmarks.
To find out more about how TriOptima can help, visit https://www.cmegroup.com/services/trioptima/trireduce-portfolio-compression/interest-rates/benchmark-conversion.html or contact us at email@example.com.
As the world’s leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana.
All information contained herein (“Information”) is for informational purposes only, is confidential and is the intellectual property of CME Group Inc and/or one of its group companies (“CME”). The Information is directed to Equivalent Counterparties and Professional Clients only and is not intended for Non-Professional Clients (as defined in the Swedish Securities Market Law (lag (2007:528) om värdepappersmarknaden)) or equivalent in a relevant jurisdiction. This Information is not, and should not be construed as, an offer or solicitation to sell or buy any product, investment, security or any other financial instrument or to participate in any particular trading strategy. The Information is not to be relied upon and is not warranted, either expressly or by implication, as to completeness, timeliness, accuracy, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed. Access to the Information by anyone other than the intended recipient is unauthorized and any disclosure, copying or redistribution is prohibited without CME’s prior written approval. If you receive this information in error, please immediately delete all copies of it and notify the sender. In no circumstances will CME be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. CME and the CME logo are trademarks of CME Group. TriOptima AB is regulated by the Swedish Financial Supervisory Authority for the reception and transmission of orders in relation to one or more financial instruments. TriOptima AB is registered with the US National Futures Association as an introducing broker. For further regulatory information, please see www.cmegroup.com.
TriOptima AB. Registered Address: Mäster Samuelsgatan 17, 111 44 Stockholm, Sweden.
Org no.: 556584-9758.
Copyright © 2021 CME Group Inc. All rights reserved.